Comment: Several commenters requested that CMS not finalize the proposed APC assignment for CPT code 0868T
After 64 weeks, the maximum Wegovy pill dose has been shown to help people lose, on average, 16.6% of their starting body weight
What factors could limit the widespread adoption of GLP-1 receptor agonists despite their proven benefits in HbA1c reduction, weight loss, and cardiovascular risk management, and how might healthcare systems address these barriers
Behavioral risks: Vaping perpetuates the hand-to-mouth behavior and reward cycle, making cessation more challenging in the future
Responsive customer support
[28] A 2014 meta-analysis found no evidence for increased pancreatic cancer risk in people treated with DPP-4 inhibitors, but owing to the modest amount of data available, the authors were unable to completely exclude possibly increased risk